1. Home
  2. DSC vs VCRE Comparison

DSC vs VCRE Comparison

Compare DSC & VCRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSC

DSC Holdings Ltd. American Depositary Shares

N/A

Current Price

$6.57

Market Cap

345.5M

Sector

Technology

ML Signal

N/A

Logo Vicore Pharma Holding AB American Depositary Shares

VCRE

Vicore Pharma Holding AB American Depositary Shares

N/A

Current Price

$9.55

Market Cap

316.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
DSC
VCRE
Founded
N/A
N/A
Country
China
Sweden
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
345.5M
316.4M
IPO Year
2023
2026

Fundamental Metrics

Financial Performance
Metric
DSC
VCRE
Price
$6.57
$9.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 41.9K
15.8K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.52
$9.64
52 Week High
$9.60
$13.15

Technical Indicators

Market Signals
Indicator
DSC
VCRE
Relative Strength Index (RSI) 40.60 N/A
Support Level $4.69 N/A
Resistance Level $6.70 N/A
Average True Range (ATR) 0.69 0.00
MACD -0.22 0.00
Stochastic Oscillator 25.74 0.00

Price Performance

Historical Comparison
DSC
VCRE

About DSC DSC Holdings Ltd. American Depositary Shares

DSC Holdings Ltd is an AI application infrastructure for China's used car industry. According to CIC, the Company has held over 90% market share in operating systems for China's used car dealers, giving it nationwide dealer connections and massive, granular, proprietary, real-time industry data. Building on this digital foundation, the group further supports used car dealers with essential transaction services across their workflows. Its Services engage and benefit thousands of dealer collaborators, such as inspectors, transporters, and other internet platforms, creating an ecosystem with used car dealers at its center.

About VCRE Vicore Pharma Holding AB American Depositary Shares

Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.

Share on Social Networks: